How Gum Disease Bacteria May Weaken Brain Defenses Against Alzheimer's | Research

The takeaway

Porphyromonas gingivalis, the bacterium behind chronic gum disease, may contribute to Alzheimer's by systematically disabling innate immune proteins including antimicrobial peptides like LL-37.

LL-37 blocks amyloid
This antimicrobial peptide can bind Aβ and prevent plaque formation — but P. gingivalis degrades it

What the researchers found

P. gingivalis infection may dysregulate and weaken innate immunity by degrading antimicrobial peptides (LL-37), Apolipoprotein E, interferons, and TNF-α, potentially enabling Alzheimer's disease pathology.

Why it matters

If gum disease bacteria truly contribute to Alzheimer's through immune disruption, oral health interventions could become a novel strategy for dementia prevention.

How the study worked

Perspective/hypothesis paper reviewing evidence linking P. gingivalis-mediated innate immune dysregulation to Alzheimer's disease etiology.

What this study cannot tell us

Perspective paper presenting a hypothesis — not a clinical study. Causal relationship between P. gingivalis and Alzheimer's remains unproven in humans.

How to read the evidence

Perspective/hypothesis paper — synthesizes existing evidence to propose a mechanism but does not test it directly.

When this study was published

Published in 2026; builds on the growing infection hypothesis of Alzheimer's disease.

The bigger picture

This connects oral health, antimicrobial peptides, and neurodegeneration in a unified framework, supporting the growing infection hypothesis of Alzheimer's disease.

Questions still open

Could treating chronic periodontitis reduce Alzheimer's disease risk?
Can restoring LL-37 levels in the brain slow amyloid plaque formation?

Common questions

Can gum disease cause Alzheimer's?

This paper proposes a mechanism by which chronic gum disease bacteria could contribute to Alzheimer's by weakening brain immune defenses, but this hypothesis requires clinical validation.

What is LL-37?

LL-37 is a natural antimicrobial peptide produced by the human immune system that can kill bacteria and, importantly, can bind to amyloid-beta and prevent the plaque formation associated with Alzheimer's disease.

Read the original research

The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease.

Journal of internal medicine, 299(3), 328-348

View on PubMed ↗Publisher’s paper ↗

Citation

Barron, Annelise E; Lin, Jennifer S; Ryder, Mark I; Bergman, Peter. (2026). The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease.. Journal of internal medicine, 299(3), 328-348. https://doi.org/10.1111/joim.70060